Literature DB >> 34514330

A novel IgM intranasal intervention against SARS-CoV-2.

Antony Yerabham1, Mitchell Ho1,2.   

Abstract

Entities:  

Keywords:  COVID-19; IgM; SARS-CoV-2; intranasal delivery; neutralizing antibodies; receptor-binding domain (RBD)

Year:  2021        PMID： 34514330      PMCID： PMC8428152          DOI： 10.1093/abt/tbab019

Source DB:  PubMed          Journal:  Antib Ther        ISSN： 2516-4236


× No keyword cloud information.
  10 in total

1.  Publisher Correction: COVID-19 antibodies on trial.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2021-01-08       Impact factor: 54.908

2.  Bispecific antibodies poised to deliver wave of cancer therapies.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2021-03       Impact factor: 54.908

3.  Structural insights into immunoglobulin M.

Authors:  Yaxin Li; Guopeng Wang; Ningning Li; Yuxin Wang; Qinyu Zhu; Huarui Chu; Wenjun Wu; Ying Tan; Feng Yu; Xiao-Dong Su; Ning Gao; Junyu Xiao
Journal:  Science       Date:  2020-02-06       Impact factor: 47.728

4.  Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.

Authors:  Zhiqiang Ku; Xuping Xie; Paul R Hinton; Xinli Liu; Xiaohua Ye; Antonio E Muruato; Dean C Ng; Sujit Biswas; Jing Zou; Yang Liu; Deepal Pandya; Vineet D Menachery; Sachi Rahman; Yu-An Cao; Hui Deng; Wei Xiong; Kevin B Carlin; Junquan Liu; Hang Su; Elizabeth J Haanes; Bruce A Keyt; Ningyan Zhang; Stephen F Carroll; Pei-Yong Shi; Zhiqiang An
Journal:  Nature       Date:  2021-06-03       Impact factor: 49.962

Review 5.  Diagnostics for SARS-CoV-2 infections.

Authors:  Bhavesh D Kevadiya; Jatin Machhi; Jonathan Herskovitz; Maxim D Oleynikov; Wilson R Blomberg; Neha Bajwa; Dhruvkumar Soni; Srijanee Das; Mahmudul Hasan; Milankumar Patel; Ahmed M Senan; Santhi Gorantla; JoEllyn McMillan; Benson Edagwa; Robert Eisenberg; Channabasavaiah B Gurumurthy; St Patrick M Reid; Chamindie Punyadeera; Linda Chang; Howard E Gendelman
Journal:  Nat Mater       Date:  2021-02-15       Impact factor: 47.656

6.  No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.

Authors:  Lucy van Dorp; Damien Richard; Cedric C S Tan; Liam P Shaw; Mislav Acman; François Balloux
Journal:  Nat Commun       Date:  2020-11-25       Impact factor: 14.919

7.  Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.

Authors:  Zhiqiang Ku; Xuping Xie; Edgar Davidson; Xiaohua Ye; Hang Su; Vineet D Menachery; Yize Li; Zihao Yuan; Xianwen Zhang; Antonio E Muruato; Ariadna Grinyo I Escuer; Breanna Tyrell; Kyle Doolan; Benjamin J Doranz; Daniel Wrapp; Paul F Bates; Jason S McLellan; Susan R Weiss; Ningyan Zhang; Pei-Yong Shi; Zhiqiang An
Journal:  Nat Commun       Date:  2021-01-20       Impact factor: 14.919

8.  SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.

Authors:  Markus Hoffmann; Prerna Arora; Rüdiger Groß; Alina Seidel; Bojan F Hörnich; Alexander S Hahn; Nadine Krüger; Luise Graichen; Heike Hofmann-Winkler; Amy Kempf; Martin S Winkler; Sebastian Schulz; Hans-Martin Jäck; Bernd Jahrsdörfer; Hubert Schrezenmeier; Martin Müller; Alexander Kleger; Jan Münch; Stefan Pöhlmann
Journal:  Cell       Date:  2021-03-20       Impact factor: 41.582

Review 9.  Neutralizing monoclonal antibodies for treatment of COVID-19.

Authors:  Peter C Taylor; Andrew C Adams; Matthew M Hufford; Inmaculada de la Torre; Kevin Winthrop; Robert L Gottlieb
Journal:  Nat Rev Immunol       Date:  2021-04-19       Impact factor: 108.555

10.  REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.

Authors:  David M Weinreich; Sumathi Sivapalasingam; Thomas Norton; Shazia Ali; Haitao Gao; Rafia Bhore; Bret J Musser; Yuhwen Soo; Diana Rofail; Joseph Im; Christina Perry; Cynthia Pan; Romana Hosain; Adnan Mahmood; John D Davis; Kenneth C Turner; Andrea T Hooper; Jennifer D Hamilton; Alina Baum; Christos A Kyratsous; Yunji Kim; Amanda Cook; Wendy Kampman; Anita Kohli; Yessica Sachdeva; Ximena Graber; Bari Kowal; Thomas DiCioccio; Neil Stahl; Leah Lipsich; Ned Braunstein; Gary Herman; George D Yancopoulos
Journal:  N Engl J Med       Date:  2020-12-17       Impact factor: 91.245
  10 in total
  2 in total

Review 1.  Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology.

Authors:  Samuel Ken-En Gan; Ser-Xian Phua; Joshua Yi Yeo
Journal:  Antib Ther       Date:  2022-02-21

2.  Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells.

Authors:  Yuanzhi Chen; Chenguang Shen; Jing Chen; Junyu Chen; Fentian Chen; Limin Zhang; Xue Liu; Siyuan Chen; Sen Xue; Yongliang Liu; Jixian Tang; Quan Yuan; Yixin Chen; Wenxin Luo; Ningshao Xia
Journal:  Virol Sin       Date:  2022-03-22       Impact factor: 6.947
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.